US Stock MarketDetailed Quotes

LXEO Lexeo Therapeutics

Watchlist
  • 4.100
  • -0.010-0.24%
Close Mar 28 16:00 ET
  • 4.200
  • +0.100+2.44%
Post 20:01 ET
136.11MMarket Cap-1.33P/E (TTM)

Lexeo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
54.37%105.77M
82.86%27.38M
55.59%31.54M
68.52%23.55M
20.74%23.29M
12.02%68.51M
-1.47%14.97M
12.55%20.27M
-8.95%13.98M
19.29M
Selling and administrative expenses
105.91%31.68M
33.29%9.02M
168.25%8.12M
155.20%6.99M
164.69%7.55M
28.18%15.38M
77.53%6.76M
14.18%3.03M
-11.10%2.74M
--2.85M
-General and administrative expense
105.91%31.68M
33.29%9.02M
168.25%8.12M
155.20%6.99M
164.69%7.55M
28.18%15.38M
77.53%6.76M
14.18%3.03M
-11.10%2.74M
--2.85M
Research and development costs
39.45%74.09M
123.70%18.37M
35.82%23.42M
47.38%16.56M
-4.23%15.74M
8.07%53.13M
-27.90%8.21M
12.26%17.25M
-8.40%11.24M
--16.44M
Operating profit
-54.37%-105.77M
-82.86%-27.38M
-55.59%-31.54M
-68.52%-23.55M
-20.74%-23.29M
-13.23%-68.51M
1.47%-14.97M
-15.96%-20.27M
8.73%-13.98M
-19.29M
Net non-operating interest income expense
179.56%7.44M
38.59%1.46M
371.79%2.06M
330.73%2.31M
153.38%1.61M
115.72%2.66M
69.13%1.05M
2.11%436K
219.64%537K
637K
Non-operating interest income
164.35%7.58M
35.03%1.49M
328.69%2.09M
297.97%2.35M
140.32%1.65M
116.38%2.87M
63.02%1.1M
7.02%488K
233.33%590K
--687K
Non-operating interest expense
-33.17%137K
-40.00%30K
-32.69%35K
-33.96%35K
-26.00%37K
125.27%205K
-7.41%50K
79.31%52K
488.89%53K
--50K
Other net income (expense)
98.34%-9K
0
98.89%-3K
66.67%-1K
-25.00%-5K
-27,050.00%-543K
-265K
-271K
-3K
-4K
Gain on sale of security
----
----
----
----
----
---530K
---258K
---272K
----
----
Other non- operating income (expenses)
30.77%-9K
--0
-400.00%-3K
66.67%-1K
-25.00%-5K
-550.00%-13K
---7K
--1K
---3K
---4K
Income before tax
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-18.66M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-18.66M
Net income continuous Operations
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
---18.66M
Minority interest income
Net income attributable to the parent company
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-18.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
11.24%-13.44M
-18.66M
Basic earnings per share
75.08%-3.09
-46.50%-0.78
-11.40%-0.89
-19.85%-0.64
-3.88%-0.77
-426.51%-12.4
8.07%-0.5324
-17.90%-0.7989
11.24%-0.534
-0.7413
Diluted earnings per share
75.08%-3.09
-46.50%-0.78
-11.40%-0.89
-19.85%-0.64
-3.88%-0.77
-426.51%-12.4
8.07%-0.5324
-17.90%-0.7989
11.24%-0.534
-0.7413
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 54.37%105.77M82.86%27.38M55.59%31.54M68.52%23.55M20.74%23.29M12.02%68.51M-1.47%14.97M12.55%20.27M-8.95%13.98M19.29M
Selling and administrative expenses 105.91%31.68M33.29%9.02M168.25%8.12M155.20%6.99M164.69%7.55M28.18%15.38M77.53%6.76M14.18%3.03M-11.10%2.74M--2.85M
-General and administrative expense 105.91%31.68M33.29%9.02M168.25%8.12M155.20%6.99M164.69%7.55M28.18%15.38M77.53%6.76M14.18%3.03M-11.10%2.74M--2.85M
Research and development costs 39.45%74.09M123.70%18.37M35.82%23.42M47.38%16.56M-4.23%15.74M8.07%53.13M-27.90%8.21M12.26%17.25M-8.40%11.24M--16.44M
Operating profit -54.37%-105.77M-82.86%-27.38M-55.59%-31.54M-68.52%-23.55M-20.74%-23.29M-13.23%-68.51M1.47%-14.97M-15.96%-20.27M8.73%-13.98M-19.29M
Net non-operating interest income expense 179.56%7.44M38.59%1.46M371.79%2.06M330.73%2.31M153.38%1.61M115.72%2.66M69.13%1.05M2.11%436K219.64%537K637K
Non-operating interest income 164.35%7.58M35.03%1.49M328.69%2.09M297.97%2.35M140.32%1.65M116.38%2.87M63.02%1.1M7.02%488K233.33%590K--687K
Non-operating interest expense -33.17%137K-40.00%30K-32.69%35K-33.96%35K-26.00%37K125.27%205K-7.41%50K79.31%52K488.89%53K--50K
Other net income (expense) 98.34%-9K098.89%-3K66.67%-1K-25.00%-5K-27,050.00%-543K-265K-271K-3K-4K
Gain on sale of security -----------------------530K---258K---272K--------
Other non- operating income (expenses) 30.77%-9K--0-400.00%-3K66.67%-1K-25.00%-5K-550.00%-13K---7K--1K---3K---4K
Income before tax -48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M11.24%-13.44M-18.66M
Income tax 0000000000
Net income -48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M11.24%-13.44M-18.66M
Net income continuous Operations -48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M11.24%-13.44M---18.66M
Minority interest income
Net income attributable to the parent company -48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M11.24%-13.44M-18.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M11.24%-13.44M-18.66M
Basic earnings per share 75.08%-3.09-46.50%-0.78-11.40%-0.89-19.85%-0.64-3.88%-0.77-426.51%-12.48.07%-0.5324-17.90%-0.798911.24%-0.534-0.7413
Diluted earnings per share 75.08%-3.09-46.50%-0.78-11.40%-0.89-19.85%-0.64-3.88%-0.77-426.51%-12.48.07%-0.5324-17.90%-0.798911.24%-0.534-0.7413
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.950
eBay
EBAY
67.160
Collegium Pharmaceutical
COLL
29.710
4
Dorian LPG
LPG
22.500
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
12.325
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.